Synopsis
Synopsis
0
CEP/COS
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Citicoline Sodium
2. 33818-15-4
3. Citicoline Sodium Salt
4. Cytidine 5'-diphosphocholine Sodium
5. Cdp-choline Sodium
6. Citicoline, Sodium
7. Cdp-choline, Sodium
8. Cytidine 5'-diphosphocholine Sodium Salt
9. Cytidine 5'-diphosphocholine Sodium Salt Dihydrate
10. Cytidine-5'-diphosphocholine Monosodium Salt
11. A821952
12. Sodium [[(2s,3r,4s,5s)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-oxido-phosphoryl] 2-(trimethylammonio)ethyl Phosphate;citicoline Sodium Salt
| Molecular Weight | 510.31 g/mol |
|---|---|
| Molecular Formula | C14H25N4NaO11P2 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 10 |
| Exact Mass | 510.08927590 g/mol |
| Monoisotopic Mass | 510.08927590 g/mol |
| Topological Polar Surface Area | 216 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 813 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
API SUPPLIERS
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Jai Radhe Sales is your partner for all your sourcing needs.
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
SNJ Labs: WHO-GMP certified API leader in India, specializing in bulk drugs & intermediates with unmatched expertise.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39545
Submission : 2024-02-16
Status : Active
Type : II
Date of Issue : 2025-08-08
Valid Till : 2028-08-07
Written Confirmation Number : WC-0617
Address of the Firm :
PI Health Sciences: Biotech for Hire providing end-to-end discovery and development powered by chemistry, biology, and AI.
Enaltec Labs –Delivering complex APIs with precision, innovation, and global compliance.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27708
Submission : 2013-11-11
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12724
Submission : 1997-10-20
Status : Inactive
Type : II
Registration Number : 307MF10110
Registrant's Address : 1-6-1 Otemachi, Chiyoda-ku, Tokyo
Initial Date of Registration : 2025-08-28
Latest Date of Registration :
Date of Issue : 2025-07-11
Valid Till : 2028-07-02
Written Confirmation Number : WC-0097
Address of the Firm :
Date of Issue : 2024-09-20
Valid Till : 2027-09-19
Written Confirmation Number : WC-592
Address of the Firm :
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
SNJ Labs: WHO-GMP certified API leader in India, specializing in bulk drugs & intermediates with unmatched expertise.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39545
Submission : 2024-02-16
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12724
Submission : 1997-10-20
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27708
Submission : 2013-11-11
Status : Inactive
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]JDMF
Japanese Pharmacopoeia Citicoline (for manufacturing purposes only)
Registration Number : 307MF10110
Registrant's Address : 1-6-1 Otemachi, Chiyoda-ku, Tokyo
Initial Date of Registration : 2025-08-28
Latest Date of Registration : 2025-08-28
Japanese Pharmacopoeia Citicoline (for manufacturing purposes only)
Registration Number : 217MF10245
Registrant's Address : 1-6-1 Otemachi, Chiyoda-ku, Tokyo
Initial Date of Registration : 2005-06-15
Latest Date of Registration : 2017-04-14
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
SNJ Labs: WHO-GMP certified API leader in India, specializing in bulk drugs & intermediates with unmatched expertise.
Date of Issue : 2025-08-08
Valid Till : 2028-08-07
Written Confirmation Number : WC-0617
Address of the Firm : Survey No. 247/1, Village: Hadala, Taluka: Rajkot,\r\nDistrict. -Rajkot, Gujarat...
Date of Issue : 2024-06-10
Valid Till : 2027-06-09
Written Confirmation Number : WC-481
Address of the Firm : Vill.Jaula Khurad, Tehsil Derabassi, Distt.Sahibzada Ajit Singh Nagar, Punjab
Date of Issue : 2024-06-10
Valid Till : 2027-06-09
Written Confirmation Number : WC-0481
Address of the Firm : Vill.Jaula Khurad, Tehsil Derabassi, Distt.Sahibzada Ajit Singh Nagar, Punjab
Date of Issue : 2024-09-20
Valid Till : 2027-09-19
Written Confirmation Number : WC-592
Address of the Firm : Plot No. 411/1, L.I.C. Sector, Silvassa Road, G.I.D.C., Vapi, Dist -Valsad -3961...
Date of Issue : 2025-07-11
Valid Till : 2028-07-02
Written Confirmation Number : WC-0097
Address of the Firm : Block No. 251/B, 252/B, 253, 254, 255, 256, 258/B, 276, 277, 278/P, 279, 280, 28...
Date of Issue : 2025-07-11
Valid Till : 2028-07-02
Written Confirmation Number : WC-0097
Address of the Firm : Block No. 251/B, 252/B, 253, 254, 255, 256, 258/B, 276, 277, 278/P, 279, 280, 28...
Date of Issue : 2022-12-30
Valid Till : 2025-12-29
Written Confirmation Number : WC-05450
Address of the Firm : PlotNo.:SP4-4,Industrial Area,Keshwana Rajput, Shahpura, Distt.Jaipur-303108, Ra...
Date of Issue : 2022-12-30
Valid Till : 2025-12-29
Written Confirmation Number : WC-0545
Address of the Firm : Plot No.: SP4-4, Industrial Area, Keshwana Rajput, Shahpura, Distt. Jaipur-30310...
Date of Issue : 2024-05-29
Valid Till : 2027-03-04
Written Confirmation Number : WC-0294
Address of the Firm : 120 A & B, 120P and 121, Industrial Area, Baikampady, New Mangalore -575011, Ind...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
Details:
Magnesium is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in Undisclosed clinical studies for the treatment of Stress Disorders, Traumatic.
Lead Product(s): Magnesium,Sodium,Creatine Monohydrate,Magnesium Gluconate,L Tyrosine Excipient,Phosphatidylserine,L-Theanine,Citicoline Sodium,Rhodiola Rosea Root Extract
Therapeutic Area: Psychiatry/Psychology Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Vitamins/Minerals/Inorganic Salts
Sponsor: Sköshify
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable January 06, 2026
Lead Product(s) : Magnesium, Sodium, Creatine Monohydrate, Magnesium Gluconate, L Tyrosine Excipient
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Sköshify
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Magnesium is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in Undisclosed clinical studies for the treatment of Stress Disorders, Traumatic.
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
January 06, 2026
Details:
Citicoline is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of unspecified medical condition.
Lead Product(s): Citicoline Sodium,Inapplicable
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Dietary Supplement
Sponsor: The Center for Applied Health Sciences
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable July 28, 2025
Lead Product(s) : Citicoline Sodium,Inapplicable
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : The Center for Applied Health Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Evaluate the Effects of Citicoline on Mood in Healthy Adults
Details : Citicoline is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of unspecified medical condition.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
July 28, 2025
Details:
Citicoline is a Dietary Supplement drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Glaucoma, Open-Angle.
Lead Product(s): Citicoline Sodium,Inapplicable
Therapeutic Area: Ophthalmology Brand Name: Undisclosed
Study Phase: Phase IIIProduct Type: Dietary Supplement
Sponsor: OPIS Spain
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable February 02, 2023
Lead Product(s) : Citicoline Sodium,Inapplicable
Therapeutic Area : Ophthalmology
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : OPIS Spain
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Citicoline is a Dietary Supplement drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Glaucoma, Open-Angle.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
February 02, 2023
Details:
Citicoline is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Lead Product(s): Citicoline Sodium,Inapplicable
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Dietary Supplement
Sponsor: Biofortis Clinical Research, Inc.
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable July 19, 2021
Lead Product(s) : Citicoline Sodium,Inapplicable
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Biofortis Clinical Research, Inc.
Deal Size : Inapplicable
Deal Type : Inapplicable
Cognitive Effects of Citicoline on Attention in Healthy Mean and Women
Details : Citicoline is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
July 19, 2021
Details:
Citicoline is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Lead Product(s): Citicoline Sodium,Omega-3
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Dietary Supplement
Sponsor: Oregon Health and Science University
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable February 23, 2018
Lead Product(s) : Citicoline Sodium,Omega-3
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Oregon Health and Science University
Deal Size : Inapplicable
Deal Type : Inapplicable
The Combination Effect of Citicoline and Omega-3
Details : Citicoline is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
February 23, 2018
Details:
Citicoline is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Lead Product(s): Citicoline Sodium,Inapplicable
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Dietary Supplement
Sponsor: Biofortis Clinical Research, Inc.
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable December 12, 2017
Lead Product(s) : Citicoline Sodium,Inapplicable
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Biofortis Clinical Research, Inc.
Deal Size : Inapplicable
Deal Type : Inapplicable
Cognitive Effects of Citicoline in Men and Women With Age-Associated Memory Impairment
Details : Citicoline is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
December 12, 2017
Details:
Citicoline is a Dietary Supplement drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Osteoarthritis.
Lead Product(s): Citicoline Sodium,Platelet Rich Plasma
Therapeutic Area: Musculoskeletal Brand Name: Undisclosed
Study Phase: Phase IIProduct Type: Dietary Supplement
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable July 26, 2016
Lead Product(s) : Citicoline Sodium,Platelet Rich Plasma
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Citicoline is a Dietary Supplement drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Osteoarthritis.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
July 26, 2016
Details:
Citicoline is a Dietary Supplement drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Osteoarthritis.
Lead Product(s): Citicoline Sodium,Platelet Rich Plasma
Therapeutic Area: Musculoskeletal Brand Name: Undisclosed
Study Phase: Phase IIProduct Type: Dietary Supplement
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable July 26, 2016
Lead Product(s) : Citicoline Sodium,Platelet Rich Plasma
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Citicoline is a Dietary Supplement drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Osteoarthritis.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
July 26, 2016
Details:
Citicoline is a Dietary Supplement drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Osteoarthritis.
Lead Product(s): Citicoline Sodium,Platelet Rich Plasma
Therapeutic Area: Musculoskeletal Brand Name: Undisclosed
Study Phase: Phase IIProduct Type: Dietary Supplement
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable July 26, 2016
Lead Product(s) : Citicoline Sodium,Platelet Rich Plasma
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Citicoline is a Dietary Supplement drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Osteoarthritis.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
July 26, 2016
Details:
Citicoline is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Lead Product(s): Citicoline Sodium,Inapplicable
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Dietary Supplement
Sponsor: University of Cincinnati
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable March 10, 2016
Lead Product(s) : Citicoline Sodium,Inapplicable
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : University of Cincinnati
Deal Size : Inapplicable
Deal Type : Inapplicable
Citicoline Effects on Cortical Membrane Structure and Function
Details : Citicoline is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
March 10, 2016
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
41
PharmaCompass offers a list of Citicoline Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Citicoline Sodium manufacturer or Citicoline Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Citicoline Sodium manufacturer or Citicoline Sodium supplier.
PharmaCompass also assists you with knowing the Citicoline Sodium API Price utilized in the formulation of products. Citicoline Sodium API Price is not always fixed or binding as the Citicoline Sodium Price is obtained through a variety of data sources. The Citicoline Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CDP-cholin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CDP-cholin, including repackagers and relabelers. The FDA regulates CDP-cholin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CDP-cholin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CDP-cholin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CDP-cholin supplier is an individual or a company that provides CDP-cholin active pharmaceutical ingredient (API) or CDP-cholin finished formulations upon request. The CDP-cholin suppliers may include CDP-cholin API manufacturers, exporters, distributors and traders.
click here to find a list of CDP-cholin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A CDP-cholin DMF (Drug Master File) is a document detailing the whole manufacturing process of CDP-cholin active pharmaceutical ingredient (API) in detail. Different forms of CDP-cholin DMFs exist exist since differing nations have different regulations, such as CDP-cholin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A CDP-cholin DMF submitted to regulatory agencies in the US is known as a USDMF. CDP-cholin USDMF includes data on CDP-cholin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The CDP-cholin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of CDP-cholin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The CDP-cholin Drug Master File in Japan (CDP-cholin JDMF) empowers CDP-cholin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the CDP-cholin JDMF during the approval evaluation for pharmaceutical products. At the time of CDP-cholin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of CDP-cholin suppliers with JDMF on PharmaCompass.
A CDP-cholin written confirmation (CDP-cholin WC) is an official document issued by a regulatory agency to a CDP-cholin manufacturer, verifying that the manufacturing facility of a CDP-cholin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting CDP-cholin APIs or CDP-cholin finished pharmaceutical products to another nation, regulatory agencies frequently require a CDP-cholin WC (written confirmation) as part of the regulatory process.
click here to find a list of CDP-cholin suppliers with Written Confirmation (WC) on PharmaCompass.
CDP-cholin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CDP-cholin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CDP-cholin GMP manufacturer or CDP-cholin GMP API supplier for your needs.
A CDP-cholin CoA (Certificate of Analysis) is a formal document that attests to CDP-cholin's compliance with CDP-cholin specifications and serves as a tool for batch-level quality control.
CDP-cholin CoA mostly includes findings from lab analyses of a specific batch. For each CDP-cholin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CDP-cholin may be tested according to a variety of international standards, such as European Pharmacopoeia (CDP-cholin EP), CDP-cholin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CDP-cholin USP).
